CERTIFICATE FREE SALE-FEES
SB2122 amends the Illinois Food, Drug and Cosmetic Act to increase the fee charged by the Illinois Department of Public Health for issuing a certificate of free sale, health certificate, or an equivalent document. The bill raises the fee from $10 to $65 for Illinois food, dairy, drug, cosmetic, and medical device manufacturers, processors, packers, and warehousers.
A certificate of free sale or health certificate is commonly used by businesses to show that products are legally sold or manufactured in Illinois and may be needed for domestic or international commerce. By updating the fee schedule, the bill would increase the cost of obtaining these documents for affected businesses while leaving the underlying certification process in place.
The bill would amend Section 21.3 of the Illinois Food, Drug and Cosmetic Act, changing a specific Department of Public Health fee from $10 to $65. Its direct legal effect is limited to the amount charged for certificates of free sale, health certificates, or equivalent certifications issued to covered food, dairy, drug, cosmetic, and medical device businesses. The bill does not change product safety standards or licensing requirements, but it would increase compliance costs for entities that rely on these certificates for sales, export, or regulatory purposes.
No committee transcript or recorded vote is provided, so there is no documented debate or formal vote history to indicate broad support or opposition. Based on the bill text alone, the measure appears administrative and fee-focused rather than policy-driven, suggesting a neutral to modestly practical framing. The available context does not show any public sentiment, amendments, or partisan division.
The main point of potential contention is the fee increase itself: affected manufacturers, processors, packers, and warehousers may view the jump from $10 to $65 as a significant added cost, especially for businesses that request these certificates frequently. Supporters would likely characterize the increase as a routine adjustment to better align fees with administrative costs, but no recorded discussion is available to confirm either side’s arguments. Because there are no transcripts or votes, no specific lawmakers or stakeholder groups are identified as having formally raised objections.